Biotechnology Stocks Scatter Chart

63 companies Industry in Healthcare P/E vs Revenue Growth (1y) (TTM)
Universe
Plot any two of 343 metrics The preset pairs are free. Subscribers can put any metric on either axis.
Highlight

P/E vs Revenue Growth (1y) (TTM)

Company Outlier, pinned to the edge Highlighted Trend

Each dot is one of the 63 Biotechnology stocks, sized by market cap. The median Revenue Growth (1y) (TTM) is 22.3% and the median P/E 16.31. Pinned to the edge: 7 outliers on X and 4 on Y.

Rank correlation -0.08 Trend R² 0.01 X middle half 7.4% to 65.2% Y middle half 5.63 to 34.06
14High Revenue Growth (1y) (TTM), high P/E
18Low Revenue Growth (1y) (TTM), high P/E
13Low Revenue Growth (1y) (TTM), low P/E
18High Revenue Growth (1y) (TTM), low P/E

Quadrants split at the medians. Hover a dot for its true values; click to open the company. Outliers are more than 3× the interquartile range beyond the quartiles.

Companies

63 plotted
# Industry
1 LLYEli Lilly 45.5% 46.74 $1.36T Pharmaceuticals
2 JNJJohnson & Johnson 7.8% 42.83 $688.76B Pharmaceuticals
3 ABBVAbbVie 10.7% 50.48 $521.69B Pharmaceuticals
4 MRKMerck 4.9% 148.68OUT $364.31B Pharmaceuticals
5 AZNAstrazeneca 7.8% 25.92 $285.96B Pharmaceuticals
6 AMGNAmgen 8.2% 26.83 $251.88B Biotechnology
7 VRTXVertex Pharmaceuticals 10.5% 34.34 $136.55B Biotechnology
8 BMYBristol Myers Squibb 4.2% 14.02 $129.66B Pharmaceuticals
9 GSKGsk 82.9% 8.11 $108.86B Pharmaceuticals
10 REGNRegeneron Pharmaceuticals 18.6% 20.17 $97.17B Biotechnology
11 ARGXArgenx Se 61.5% 31.35 $59.41B Biotechnology
12 SNYSanofi -19.6% 6.24 $58.98B Pharmaceuticals
13 TEVATeva Pharmaceutical Industries 2.7% 102.64 $51.97B Generic Drugs
14 ONCBeOne Medicines 32.9% 51.73 $47.53B Pharmaceuticals
15 BIIBBiogen 2.3% 107.78 $37.46B Biotechnology
16 ALNYAlnylam Pharmaceuticals 60.8% 8.34 $22.09B Biotechnology
17 ZBHZimmer Biomet Holdings 7.0% 25.63 $19.53B Medical Devices
18 ASNDAscendis Pharma A 93.8% 16.31 $17.07B Biotechnology
19 NBIXNeurocrine Biosciences 38.0% 24.21 $16.96B Pharmaceuticals
20 EXELExelixis 9.1% 19.24 $16.88B Pharmaceuticals
21 KNSAKiniksa Pharmaceuticals International 58.2% 68.75 $15.13B Biotechnology
22 RDYDr Reddys Laboratories -10.5% 33.78 $12.31B Generic Drugs
23 HALOHalozyme Therapeutics 45.0% 23.51 $11.42B Biotechnology
24 TGTXTg Therapeutics 68.8% 85.63 $9.75B Biotechnology
25 GMEDGlobus Medical 13.4% 17.35 $9.56B Medical Devices
26 PTGXProtagonist Therapeutics 163.7% 25.39 $8.54B Biotechnology
27 LGNDLigand Pharmaceuticals 1.0% 119.78OUT $6.18B Biotechnology
28 ARQTArcutis Biotherapeutics 60.0% 123.78OUT $3.56B Biotechnology
29 TAKTakeda Pharmaceutical -35.4% 10.69 $3.41B Pharmaceuticals
30 GMABGenmab A 22.5% 3.81 $3.30B Biotechnology
31 ADMAAdma Biologics 6.3% 16.78 $3.05B Biotechnology
32 LKFTLakefront Biotherapeutics 240.8%OUT 2.40 $2.24B Biotechnology
33 AUPHAurinia Pharmaceuticals 21.0% 6.68 $2.11B Pharmaceuticals
34 HRMYHarmony Biosciences Holdings 19.8% 11.04 $1.98B Pharmaceuticals
35 ZYMEZymeworks 97.8% 43.39 $1.87B Biotechnology
36 NRIXNurix Therapeutics 738.8%OUT 5.86 $1.69B Biotechnology
37 JAZZJazz Pharmaceuticals 13.5% 7.59 $1.55B Pharmaceuticals
38 ANABAnaptysbio 41.9% 87.82 $1.38B Biotechnology
39 PHARPharming -6.5% 35.82 $884.12M Biotechnology
40 RIGLRigel Pharmaceuticals 2.2% 2.71 $837.18M Biotechnology
41 ABUSArbutus Biopharma 1,143%OUT 3.70 $812.59M Biotechnology
42 IRWDIronwood Pharmaceuticals 18.1% 5.32 $799.61M Biotechnology
43 ZVRAZevra Therapeutics 75.2% 6.91 $539.71M Pharmaceuticals
44 KMDAKamada 12.6% 19.04 $466.68M Biotechnology
45 AGENAgenus 25.4% 14.31 $421.62M Biotechnology
46 PBYIPuma Biotechnology 9.4% 16.86 $401.70M Biotechnology
47 CRMDCorMedix 92.5% 5.90 $370.36M Pharmaceuticals
48 ALECAlector 151.2% 6.86 $285.18M Biotechnology
49 QTTBQ32 Bio 75.7% 120.37OUT $260.36M Biotechnology
50 INCYIncyte 24.9% 0.61 $246.78M Pharmaceuticals
51 PLXProtalix BioTherapeutics 37.0% 11.87 $245.74M Biotechnology
52 OMEROmeros 1,532%OUT 2.25 $236.99M Biotechnology
53 CGENCompugen 1,000.0%OUT 5.39 $198.56M Biotechnology
54 FHTXFoghorn Therapeutics 357.3%OUT 15.73 $124.12M Biotechnology
55 VXRTVaxart 22.3% 3.01 $87.73M Biotechnology
56 RLYBRallybio -35.6% 3.35 $83.84M Biotechnology
57 FBIOFortress Biotech 12.3% 0.65 $62.62M Biotechnology
58 ATNMActinium Pharmaceuticals 936.3%OUT 4.55 $51.56M Biotechnology
59 IBOImpact Biomedical 22.6% 27.21 $43.92M Biotechnology
60 KYNBKyntra Bio 3.0% 0.08 $13.93M Biotechnology
61 OTLCOncotelic Therapeutics 36.5% 0.02 $4.57M Biotechnology
62 OSRHOSR Health -50.4% 0.71 $3.51M Biotechnology
63 PTIXProtagenic Therapeutics, Inc.new -43.1% 0.15 $850.80K Biotechnology

Frequently Asked Questions

Which Biotechnology stocks look cheap relative to their growth?

Among Biotechnology stocks, the largest companies growing revenue faster than the median (22.3%) while trading below the median P/E (16.31) are Gsk (GSK), Alnylam Pharmaceuticals (ALNY), Genmab A (GMAB), Lakefront Biotherapeutics (LKFT) and Nurix Therapeutics (NRIX). A low multiple next to fast growth can be an opportunity or a sign the market doubts the growth will last.

Which Biotechnology stocks are expensive for their growth?

The largest companies with a P/E above the median and revenue growth below it are Johnson & Johnson (JNJ), AbbVie (ABBV), Merck (MRK), Astrazeneca (AZN) and Amgen (AMGN).

What is the median P/E of Biotechnology stocks?

The median P/E across the 63 Biotechnology stocks plotted is 16.31, with the middle half between 5.63 and 34.06.

What is the median Revenue Growth (1y) (TTM) of Biotechnology stocks?

The median is 22.3%, with the middle half between 7.4% and 65.2%.

Is there a relationship between Revenue Growth (1y) (TTM) and P/E for Biotechnology stocks?

The rank correlation (Spearman) is -0.08, a no meaningful negative relationship: knowing one tells you little about the other.

How does this chart handle outliers?

A company whose value lies more than three interquartile ranges beyond the first or third quartile is treated as an outlier. By default it stays on the chart, pinned to the edge as an open marker, and its true value is shown in the tooltip and the table. In this view 7 companies are outliers on Revenue Growth (1y) (TTM) and 4 on P/E. You can switch to percentile clamping, exclude outliers, or plot raw values on a log scale.

Metrics from Business Quant's screener: trailing-twelve-month figures from SEC filings and multiples on the latest close. A company appears once even when it lists more than one share class. A company with a secondary business line in this industry is included unless you choose primary industry only. Nothing on this page is investment advice.